SEC 13F Intelligence

Viex Capital Advisors, LLC / ENZB

Viex Capital Advisors, LLC’s Enzo Biochem Inc Position

Does Viex Capital Advisors, LLC own Enzo Biochem Inc (ENZB)? Yes — 1.33M shares worth $3M (+9.62% of its 13F portfolio) as of Q3 2022, down from 1.54M shares the prior filed quarter.

Position Value
$3M
Q3 2022
Shares
1.33M
% of Portfolio
+9.62%
Quarters Held
7
currently held

Position History ENZB

Reported value by quarter
Q4 ’20: $392,000Q4 ’20Q2 ’21: $5MQ2 ’21Q3 ’21: $5MQ3 ’21Q4 ’21: $6MQ4 ’21Q1 ’22: $4MQ1 ’22Q2 ’22: $3MQ2 ’22Q3 ’22: $3MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20221.33M$3M+9.62%
Q2 20221.54M$3M+8.40%
Q1 20221.44M$4M+7.44%
Q4 20211.74M$6M+8.96%
Q3 20211.51M$5M+3.24%
Q2 20211.50M$5M+3.40%
Q4 2020155.5K$392,000+0.32%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Viex Capital Advisors, LLC’s full portfolio or all institutional holders of ENZB.